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Background: Publications are often used as a measure of success of research work. Leishmaniasis is considered
endemic in 98 countries, most of which are developing. This article describes a bibliometric review of the literature
on leishmaniasis research indexed in PubMed during a 66-year period.
Methods: Medline was used via the PubMed online service of the US National Library of Medicine. The search
strategy was Leishmania [MeSH] or leishmaniasis [MeSH] from 1 January 1945 until 31 December 2010. Neither
language nor document type restrictions were employed.
Results: A total of 20,780 references were retrieved. The number of publications increased steadily over time, with
3,380 publications from 1945-1980 to 8,267 from 2001-2010. Leishmaniasis documents were published in 1,846
scientific journals, and Transactions of the Royal Society of Tropical Medicine and Hygiene (4.9%) was the top one. The
USA was the predominant country by considering the first author’s institutional address (16.8%), followed by Brazil
(14.9%), and then India (9.0%), however Brazil leads the scientific output in 2001-2010 period (18.5%), followed by
the USA (13.5%) and India (10%). The production ranking changed when the number of publications was
normalised by population (Israel and Switzerland), by gross domestic product (Nepal and Tunisia), and by gross
national income per capita (India and Ethiopia). For geographical area, Europe led (31.7%), followed by Latin
America (24.5%).
Conclusions: We have found an increase in the number of publications in the field of leishmaniasis. The USA and
Brazil led scientific production on leishmaniasis research.
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Leishmaniasis is a group of diseases caused by protozoan
parasites of the Leishmania genus, order Kinetoplastida.
More than 20 Leishmania species are considered human
pathogens. Leishmaniasis occurs on four continents and is
considered endemic in 98 countries and three territories,
most of which are low- and middle-income [1,2].
Leishmaniasis is a poverty-related disease in which
poverty and disease reinforce each other in a vicious cycle.
Poverty determinants like malnutrition, displacement, poor
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reproduction in any medium, provided the orweakness, and lack of resources have been reviewed else-
where [3]. Leishmaniasis is still one of the world’s most
neglected diseases; 350 million people are considered at risk
of contracting leishmaniasis, and some 1 million new cases
occur yearly [2]. In the past 10 years, there have been major
scientific breakthroughs in the treatment, diagnosis and
prevention of leishmaniasis, and the cost of several key
medicines has been reduced [4,5].
Research is important in a country’s development and
progress. Biomedical research projects usually lead to publi-
cations in the serial literature. Original articles allow investi-
gators to present their scientific observations, and the
publication of an investigator’s project allows the informa-
tion to be shared by the scientific community. Publications
are often used as a measure of success of research work. In
recent years, there has been growing interest in developingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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results of research activities [6].
The term “neglected tropical diseases”, which was coined
in the mid 1990s, has become a “brand-name” referring to
a group of diseases which are especially endemic in
low-income populations living in tropical and subtropical
countries. Since then, there has been a growing interest in
research and there are specific journals now available for
getting this research published in the peer-reviewed litera-
ture [7]. There are international bibliometric studies in
different fields of medicine [8-10] and/or tropical medicine
[11-14]. There have been publications analyzing the
research production in other neglected tropical diseases
(NTD), such as schistosomiasis [15,16], leprosy [16,17], and
Chagas disease [16,18]. As for leishmaniasis, one quantita-
tive study analysing literature research output for the period
between 1957 and 2006 using the Web of Science has been
published [19]. There are other studies analyzing the scien-
tific production and productivity of Iranian institutes in the
field of leishmaniasis using the Medline database [20]. The
PubMed database offers the possibility of analysing Medical
Subject Headings (MeSH), MeSH categories articles and
more biomedical journals than the Web of Science.
Although the previous publications allowed a bibliometric
analysis of research output on leishmaniasis, mapping leish-
maniasis research to other aspects such as authorship and
clinical forms of leishmaniasis is still pending. The aim of
this study was to investigate leishmaniasis research output
using PubMed over a period of 66 years (1945-2010) by
journal of publication; animal or human MeSH, taking
advantage of the fact that in PubMed you can filter the
search results by considering human or animal studies;
forms of the disease and author production in terms of
number of publications per author.
Methods
The Medline database, accessible free of charge through
the PubMed platform, was selected as the most suitable
for references to leishmaniasis publications due to its vol-
ume and coverage. Furthermore, it uses a controlled
vocabulary, the Medical Subject Headings (MeSH) the-
saurus, a hierarchical structure made up of 26,000 descrip-
tors and over 213,000 entry terms, which allowed us to
perform accurate searches. This database is easily access-
ible and widely used [8,9,21]. PubMed (http://www.ncbi.
nlm.nih.gov/pubmed) was accessed online on 10 February
2012. The subject content analysis of records was
conducted according to the MeSH structure. For retriev-
ing documents, a search was composed with the MeSH
terms or descriptors ‘leishmaniasis’ or ‘Leishmania’. The
study period was from 1 January 1945 to 31 December
2010, grouped by 5-year increments because PubMed ci-
tations go back to 1945. We did not consider any language
or document type restriction in the search, in order toanalyse publication patterns of all publications on
Leishmaniasis.
The document type used in our study refers to the type
of article and its financing. The impact factor of a journal
and its ranking was obtained from the Journal Citation
Report (JCR) 2010 Science Edition [22].
The productivity by country was analysed considering the
number of papers and the percentage of world production.
The institutional affiliation is only included for the first
participating author since 1986 in the PubMed database in
Journal articles and Review. Indicators of each country’s
productivity between 2001-2010 period were standardised
with respect to the population, gross domestic product
(GDP), gross national income (GNI) per capita and the
health expenditure per capita. To calculate the publications
per million inhabitants (population index), per billion of
GDP (US dollars) (GDP index), per 100 US dollars of GNI
per capita (GNI per capita index), and per 10 US dollars of
health expenditure (HE) per capita (HE per capita index),
data were obtained from Word Development Indicators
from the online databases of the World Bank [23].
Based on geographic, scientific and economic criteria,
the world was divided into seven regions: i) Europe; ii)
North America (United States of America [USA] and
Canada), iii) Latin America and the Caribbean; iv) North
Africa and the Middle East (including Turkey); v) Africa;
vi) Asia; and vii) Oceania. According to the MeSH term,
the forms of diseases were the following: ‘Leishmaniasis,
visceral’, ‘Leishmaniasis, cutaneous’, ‘Leishmaniasis mucocu-
taneous’, and ‘Leishmaniasis diffuse cutaneous’. ‘Leishman-
iasis, cutaneous’ and ‘Leishmaniasis, diffuse cutaneous’
have been included in PubMed since 1992.
The information obtained from the registers was intro-
duced into a database using Microsoft Access 2007. A
standardisation process was carried out to consolidate
variations in author names. The criterion followed in this
process was the occurrence of the institutional signature
associated with the variations in names and surnames.
Research output was analysed by country, geographic area,
and forms of leishmaniasis. Publication authorship was
analysed by the forms of leishmaniasis.
Results
In the PubMed database, 20,780 references were retrieved
for the entire study period. There were 3,380 (16.3%) publi-
cations from 1945 to 1980, 3,567 (17.2%) from 1981 to
1989, 5,566 (26.8%) from 1991 to 2000, and 8,267 from
2001 to 2010 (39.8%). Figure 1 shows the numbers of
PubMed publications on leishmaniasis research during the
66-year study period in five-year periods. The five-year
average increase of publications was +10.5% throughout the
study period, although this percentage was much higher
from 1981 to 1985 (+81.1%), 1961 to 1965 (+42.9%), and
from 1986 to 1990 (+42.3%). This percentage was less from
Figure 1 Number of leishmaniasis disease research publications in PubMed (○) between 1945 and 2010 per 5-year period.
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fitting the number of publications over time, a better fit
was observed for a straight line (coefficient of determin-
ation for linear fit, R2 = 0.91) than for an exponential curve
(R2 = 0.81).
Language of publication
The primary language was English (82.8%), followed by
French (4.2%), Portuguese (2.8%), Spanish (2.6%), Russian
(2.5%), German (1.3%), Italian (0.8%), Chinese (0.5%),
undetermined (1.8%) and others (0.8%).
Journal of publication
The 20,700 retrieved articles were published in 1,846
scientific journals. Eight journals accounted for 21.4%
of the leishmaniasis journal literature. About one-half
of the literature is concentrated in 50 journals, while
the remaining half is scattered throughout 1,796
journals. Moreover, 743 journals published only one
paper on leishmaniasis. Table 1 shows a list of the 50
journals with the highest number of papers published
from 1945-2010, as well as their impact factors for
the year 2010, subject category according to the JCR
classification and language. Seven of these journals
were not included in JCR because they did not have
an impact factor, and three of these journals were not
published in 2010. The remaining journals were in-
cluded in at least one of 22 subject categories. Trans-
actions of the Royal Society of Tropical Medicine and
Hygiene leads the number of leishmaniasis docu-
ments published during 1945-2010 period (n = 1,018).
The source journals mainly include the fields of para-
sitology (n = 13), immunology (n = 11), tropical medi-
cine (n = 9), biochemistry and molecular biology
(n = 5) and microbiology (n = 5), public health (n = 5),
among others.MeSH
The 30 most frequent MeSH words in documents pub-
lished during the 1945-2010 period about leishmaniasis
are shown in Table 2. Animals (41.2%) was the predomin-
ant MeSH, followed by Animals and Humans (29.0%),
and Humans (21.8%). Figure 2 shows the numbers of
PubMed publications on leishmaniasis research with
MeSH Animals, Animals and Humans, and Humans dur-
ing the 66-year study period by five-year periods. After fit-
ting the number of publications over time, a better fit was
observed for a straight line (R2 = 0.98) for Animals; for
Animals and Humans, a better fit was observed for an
exponential curve (R2 = 0.97) than for a straight line
(R2 = 0.91); and for Humans, a better fit was observed for
a line (R 2 =0.90) than for an exponential curve.
The MeSH visceral leishmaniasis, cutaneous leishman-
iasis, mucocutaneous leishmaniasis, and diffuse cutane-
ous leishmaniasis were reported in 29.9%, 18.5%, 4.8%
and 0.5%, respectively. Figure 3 shows the numbers of
PubMed publications by categories of leishmaniasis
during the 66-year study period per five-year period.
The main MeSH Leishmania species were L. donovani
(13.9%), L. major (9.3%), L. infantum (6.7%), L. mexicana
(5.7%), L. braziliensis (3.9%), and L. tropica (3.9%).Document type of publications
Journal articles are the most common document type,
accounting for about 86.5% of the total (n = 17,982).
Review and Letter were the second and third most com-
mon, with 1,616 (7.8%), and 1,008 (4.9%) documents, re-
spectively. Only 1.1% of the documents were subdivided
into Randomized controlled trials (n = 234), 0.8% into
Clinical trial (n = 157), and 0.3% into Controlled clinical
trials (n = 52). Case reports appeared in 2,171 (10.4%)
and Comparative study in 1,750 (8.4%) documents.





Journal category (ranking) Language
Transactions of the Royal Society of Tropical
Medicine and Hygiene
1.018 4.9 2.832 Public. Environmental & Occupational Health (30 of 142)
Eng
Tropical Medicine (4 of 19)
The American Journal of Tropical Medicine
and Hygiene
679 3.3 2.446 Public. Environmental & Occupational Health (38 of 142)
Eng
Tropical Medicine (5 of 19)
Molecular and Biochemical Parasitology 599 2.9 2.875 Biochemistry & Molecular Biology (189 of 236)
Eng
Parasitology (6 of 32)
Memórias do Instituto Oswaldo Cruz 438 2.1 2.058 Parasitology (13 of 32)
Eng
Tropical Medicine (7 of 19)
Experimental Parasitology 428 2.1 1.869 Parasitology (14 of 32) Multi
Journal of immunology (Baltimore. Md. : 1950) 427 2.1 5.747 Immunology (20 of 134) Eng
Annals of Tropical Medicine and Parasitology 426 2.1 1.579 Parasitology (20 of 32)
EngPublic. Environmental & Occupational Health (86 of 142)
Tropical Medicine (8 of 19)
Infection and Immunity 423 2.0 4.098 Immunology (33 of 134)
Eng
Infectious Diseases (11 of 58)
Meditsinskaia Parazitologiia i Parazitarnye Bolezni 352 1.7 NI - Rus
The Journal of Biological Chemistry 295 1.4 5.328 Biochemistry & Molecular Biology (50 of 286) Eng
Acta Tropica 291 1.4 2.262 Parasitology (10 of 32)
Eng
Tropical Medicine (6 of 19)
Revista da Sociedade Brasileira de Medicina Tropical 277 1.3 0.580 Tropical Medicine (14 of 19) Mul
Parasitology Research 216 1.0 1.812 Parasitology (15 of 32) Eng
Antimicrobial Agents and Chemotherapy 211 1.0 4.672 Microbiology (18 of 107)
Eng
Pharmacology & Pharmacy (26 of 252)
The Journal of Parasitology 203 1.0 1.208 Parasitology (21 of 32) Eng
Parasitology 201 1.0 2.522 Parasitology (7 of 32) Eng
International Journal of Dermatology 195 0.9 1.265 Dermatology (36 of 55) Eng
The Journal of Infectious Diseases 188 0.9 6.288 Immunology (19 of 134)
EngInfectious Diseases (5 of 58)
Microbiology (12 of 112)
Veterinary Parasitology 187 0.9 2.331 Parasitology (9 of 32)
Eng
Veterinary Sciences (9 to 145)
Journal of the Egyptian Society of Parasitology 181 0.9 NI - Eng
Revista do Instituto de Medicina Tropical de São Paulo 176 0.8 0.934 Tropical Medicine (12 of 19) Multi
European Journal of Immunology 166 0.8 4.942 Immunology (22 of 134) Eng
Vaccine 152 0.7 3.572 Immunology (43 of 134)
Eng
Medicine. Research & Experimental (25 of 106)
International Journal for Parasitology 149 0.7 3.822 Parasitology (4 of 32) Eng
Clinical Infectious Diseases 142 0.7 8.186 Immunology (11 of 134)
EngInfectious Diseases (2 of 58)
Microbiology (9 of 112)
Parasite Immunology 138 0.7 2.328 Immunology (8 of 134)
Eng
Parasitology (8 of 32)
Proceedings of the National Academy of Sciences
of the United States of America
129 0.6 9.971 Multidisciplinary Sciences (3 of 59)
Eng
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(Continued)
The Journal of Experimental Medicine 126 0.6 14.776 Immunology (2 of 134)
Eng
Medicine. Research & Experimental (5 of 106)
Clinical and Experimental Immunology 122 0.6 3.134 Immunology (56 of 134) Eng
Bulletin de la Société de Pathologie Exotique
et de ses Filiales (a)
122 0.6 NI -
Fre
Lancet 121 0.6 33.633 Medicine. General & Internal (2 of 153) Eng
Journal of Clinical Microbiology 116 0.6 4.220 Microbiology (20 of 112) Eng
Indian Journal of Medical Research 112 0.5 1.826 Immunology (106 of 134)
EngMedicine. General & Internal (44 of 153)
Medicine. Research & Experimental (56 of 106)
Tropical Medicine & International Health 109 0.5 2.967 Public. Environmental & Occupational Health (29 to 142)
Eng
Tropical Medicine (3 of 19)
The Journal of Protozoology (3)QUÉ ES ESTO 105 0.5 NI - Eng
East African Medical Journal 95 0.5 NI - Eng
Journal of Medical Entomology 94 0.5 1.925 Entomology (12 of 83)
Eng
Veterinary Sciences (15 of 145)
Parassitologia 91 0.4 NI - Ita
Nucleic Acids Research 90 0.4 3.836 Biochemistry & Molecular Biology (30 of 286) Eng
Journal of Communicable Diseases 84 0.4 NI - Eng
Annales de Parasitologie Humaine et Comparée (c) 83 0.4 NI - Fre
Trends in Parasitology 82 0.4 4.906 Parasitology (2 of 32) Eng
Microbes and Infection 82 0.4 2.726 Immunology (70 of 134)
EngMicrobiology (42 of 107)
Virology (16 of 33)
Cadernos de Saúde Pública 80 0.4 0.987 Public. Environmental & Occupational Health (107 of
142)
Por
PLoS Neglected Tropical Diseases 80 0.4 4.752 Parasitology (3 of 32)
Eng
Tropical Medicine (1 of 19)
Journal of Medicinal Chemistry 79 0.4 5.527 Chemistry. Medicinal (3 of 54) Eng
Bioorganic & Medicinal Chemistry 76 0.4 2.906 Biochemistry & Molecular Biology (134 of 286)
EngChemistry. Medicinal (15 of 54)
Chemistry. Organic (16 of 56)
The Biochemical Journal 75 0.4 5.016 Biochemistry & Molecular Biology (134 of 286) Eng
Médecine Tropicale : Revue du Corps de Santé
Colonial
75 0.4 NI -
Fre
Science (New York. N.Y.) 75 0.4 31.377 Multidisciplinary Sciences (2 of 59) Eng
Their impact factors for the year 2010. Journal category with ranking from the Journal Citation Report and language of publication.
NI: Not included in 2010 JCR Science Edition. Docs: documents.
Eng, English; Fre, French; Ita, Italian; Multi, Multi-language; Por, Portuguese; Spa, Spanish; Rus, Russian.
(a) Publication end year 1989.
(b) Publication end year 1992.
(c) Publication end year 1993.
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The first author’s institutional address was available for
13,973 of the 20,780 publication documents (67.2%).
One-hundred and seven countries published at least
one paper. USA was the predominant country (16.8%),followed by Brazil (14.9%), India (9.0%), the United
Kingdom [UK] (7.1%), France (5.8%), Spain (5.3%) and
Germany (4.2%). These seven countries contributed
63.1% of all research documents published during the
study period (1945-2010) and 30 countries contributed
Table 2 The 30 top Medical Subject Headings (MeSH)
words in leishmaniasis articles published during the
1945-2010 period
MeSH N. of documents %
Animals 8.564 41.2
Animals & Humans 6.036 29.0







Leishmaniasis. Cutaneous 3.848 18.5
Adult 3.295 15.9
Leishmania donovani 2.896 13.9
Antiprotozoal Agents 2.604 12.5
Mice. Inbred BALB C 2.125 10.2
Child 2.039 9.8
Leishmania major 1.937 9.3
Adolescent 1.825 8.8
Middle Aged 1.807 8.7
Macrophages 1.575 7.6
Dogs 1.513 7.3
Molecular Sequence Data 1.447 7.0
Antigens. Protozoan 1.447 7.0
Child. Preschool 1.428 6.9
Leishmania infantum 1.402 6.7
Insect Vectors 1.343 6.5
Protozoan Proteins 1.233 5.9
Antibodies. Protozoan 1.182 5.7
Leishmania mexicana 1.182 5.7
Psychodidae 1.126 5.4
Dog Diseases 1.125 5.4
Cricetinae 1.038 5.0
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2001 and 2010 (18.5%), followed by the USA (13.5%),
India (10%), UK (5.8%) and Spain (5.5%).
Table 3 ranks countries in crude numbers of retrieved
articles between 2001 and 2010 and numbers corrected by
population index, GDP index, GNI per capita index and
HE per capita index. When normalised by population, the
order of prominence was Israel, Switzerland, Tunisia, Malta
and Spain. Normalised by GDP, we found that among
low- and middle-income countries, Nepal, Tunisia,
Ethiopia, Sudan and Kenya were the most productive. If we
calculate the ratio of number of leishmaniasis publicationsto GNI per capita, India, Brazil, Ethiopia, Nepal and Iran
were the most productive. When normalised by HE per
capita, the leading order were overpopulated countries:
India, Ethiopia, Pakistan, Brazil and Nepal.
Table 4 ranks countries in crude numbers of retrieved
articles, stratified by forms of the leishmaniasis. For
visceral leishmaniasis, the main countries were India,
Brazil and Spain. Regarding cutaneous leishmaniasis, the
countries leading the ranking were Brazil, the USA,
and Germany. For mucocutaneous leishmaniasis, Brazil,
USA and France led; meanwhile, for diffuse cutaneous
leishmaniasis, leading countries were Brazil, Venezuela
and USA.
Publication by geographic area
Europe was by far the most productive area in the field
of leishmaniasis, responsible for 31.7% of all articles.
Latin America and the Caribbean and North America
ranked second and third, respectively, with 24.5% and
16.2% each (Table 3). The ranking corrected by popula-
tion gives the first position to Oceania followed by
North America. When normalised by GPD, GNI per
capita and HE per capita, the order of prominence was
Latin America and the Caribbean (Table 3).
Europe was the most productive in visceral leishmaniasis,
followed by Asia. Latin America and the Caribbean ranked
first in cutaneous, mucocutaneous and diffuse cutaneous
leishmaniasis (Table 4).
Every world region increased their absolute production
during the study period. Europe had more articles
published each 5-year period, but their relative contribu-
tion fell during the last one, to 29.2%. Latin America in-
creased its absolute production during the study period
and increased its relative contribution from 18.0% in
1986-1990 to 26.8% from 2006-2010. Asia increased its
absolute production during the study period, and
increased its relative contribution from 8.8% in 1986-
1990 to 20.5% in 2006-2010. The relative contribution of
North America decreased from 28.0% in 1986-1990 to
14.4% in the 2006-2010 period. The relative contribution
of North Africa and the Middle East, Africa and Oceania
was similar during all 5-year periods (Figure 4).
Authorship
Table 5 ranks the 20 most productive authors in each form
of the disease. For visceral leishmaniasis, the main author
was S. Sundar, an Indian researcher (n = 164 documents),
followed by H.W. Murray (n = 91), a North American
investigator, and L. Grandoni (n = 87), an Italian scientist.
For cutaneous leishmaniasis, the main author was P. Schott
(n = 62), a North American investigator, followed by
F. Pratlong (n = 55), a researcher from France, and D.L.
Sacks (n = 49), a North American scientist. In mucocutane-
ous leishmaniasis, P.D. Marsden (n = 68), a Brazilian, was
Figure 2 Number of leishmaniasis disease research publications in PubMed with Animals (○), Animals & Humans (Δ) and Humans (◊)
MeSH, between 1945 and 2010 per 5-year period.
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ing were J.M. Costa, J. Convit and A.C. Saldanha
(n = 11 each), among Latin American investigators.
Discussion
This study has shown an increase in the number of publica-
tions on leishmaniasis over the 1945-2010 period, which
seems to be more pronounced than that observed in other
neglected tropical diseases, such as American trypanosom-
iasis or leprosy [17,18] and global tropical medicine [12-14].
Moreover, scientific publications on leprosy have experi-
enced a reduced trend since the turn of the century [17].
This is probably related to different causes. First, the
increase in estimating the prevalence of leishmaniasis seen
in recent years [1]. Secondly, greater social awareness, in-
cluding by the pharmaceutical industry and philanthropicFigure 3 Number of leishmaniasis disease research publications in Pu
cutaneous leishmaniasis (◊), and diffuse cutaneous leishmaniasis (+) Mworld that has opened to these diseases, including the Bill
& Melinda Gates Foundation and other non-governmental
organizations. Thirdly, we do not doubt the important steps
taken by the World Health Organization (WHO) for inclu-
sion in its health agenda an initiative to control the disease
in endemic countries [2]. Fourthly, the therapeutic discov-
eries of drugs over the past 15 years (amphotericine B
liposomic, miltefosine and paromomycin), or diagnosis pro-
cedures attract much attention on leishmaniasis [2,4,24,25].
Therefore, the continuous interest in the field and the
incorporation of new journals in PubMed may have
contributed to this linear increase. In this sense, two
outstanding open access journals devoted to the study
of Tropical Diseases have been launched in recent
years: PLoS Neglected Tropical Diseases, started in
2007; and Parasites & Vectors, established in 2008. EvenbMed: visceral leishmaniasis (○), mucocutaneous leishmaniasis (Δ),
eSH, between 1945 and 2010 per 5-year period.













Brazil 1.426 18.47 Israel 16.98 Nepal 4.44 India 96.50 India 227.35
USA 1.040 13.47 Switzerland 14.28 Tunisia 3.51 Brazil 27.08 Ethiopia 39.00
India 773 10.01 Tunisia 11.89 Ethiopia 2.41 Ethiopia 19.12 Pakistan 35.79
UK 450 5.83 Malta 9.88 Sudan 1.59 Nepal 12.88 Brazil 29.52
Spain 427 5.53 Spain 9.78 Kenya 1.37 Iran 9.46 Nepal 22.11
France 376 4.87 Greece 8.63 Brazil 1.29 Pakistan 9.13 Bangladesh 13.33
Germany 302 3.91 Brazil 7.65 Iran 1.25 Sudan 7.39 Iran 13.00
Italy 291 3.77 UK 7.44 Burkina Faso 1.02 Kenya 5.21 Kenya 11.54
Iran 264 3.42 Belgium 7.40 Bolivia 0.83 Bangladesh 3.99 Sudan 11.22
Canada 213 2.76 Portugal 7.32 India 0.80 Colombia 3.77 Tunisia 6.32
Colombia 133 1.72 Canada 6.55 Sri Lanka 0.79 Tunisia 3.73 Colombia 4.94
Tunisia 120 1.55 France 5.94 Colombia 0.79 USA 2.41 Sri Lanka 4.42
Israel 119 1.54 Italy 4.95 Israel 0.77 China 2.09 China 4.22
Turkey 115 1.49 Australia 4.64 Malta 0.63 Egypt 1.94 Egypt 3.78
Venezuela 111 1.44 Czech Republic 4.27 Paraguay 0.59 Turkey 1.73 Turkey 2.77
Switzerland 107 1.39 Netherlands 4.22 Pakistan 0.56 Spain 1.73 Venezuela 2.75
Japan 101 1.31 Venezuela 4.14 Venezuela 0.55 Venezuela 1.69 Burkina Faso 2.22
Australia 96 1.24 Iran 3.76 Afghanistan 0.52 Sri Lanka 1.67 Tanzania 2.11
Greece 96 1.24 Germany 3.67 Cameroon 0.46 Burkina Faso 1.55 Iraq 1.94
Belgium 78 1.01 Sweden 3.63 Albania 0.46 Afghanistan 1.43 Spain 1.92
Portugal 77 1.00 Bahrain 3.51 Panama 0.45 UK 1.23 Cameroon 1.67
Netherlands 69 0.89 USA 3.50 Senegal 0.43 Argentina 1.19 USA 1.56
Argentina 68 0.88 Colombia 3.07 Surinam 0.42 Uganda 1.17 Morocco 1.55
Pakistan 68 0.88 Denmark 2.57 Portugal 0.40 France 1.11 UK 1.48
Mexico 65 0.84 Panama 2.45 Greece 0.39 Tanzania 1.01 Bolivia 1.47
Sudan 55 0.71 Uruguay 2.41 Jordan 0.38 Italy 0.99 Afghanistan 1.43
China 46 0.60 Austria 2.07 Uganda 0.38 Iraq 0.96 Mexico 1.34
Czech Republic 44 0.57 Surinam 2.00 Iraq 0.38 Germany 0.88 Argentina 1.33
Nepal 42 0.54 Cuba 1.96 Spain 0.37 Cameroon 0.87 Uganda 1.29
Ethiopia 39 0.51 Cyprus 1.93 Uruguay 0.36 Mexico 0.84 Yemen 1.28
World regions N. of
docs




World regions GNI per
capita
index***
World regions HE per
capita
index****













1,893 24.51 North America 3.80 North Africa 0.31 North America 1.63 Asia 1.72
North America 1,253 16.23 Latin America
and the
Caribbean
3.57 Africa 0.30 Asia 0.84 North America 1.21
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Table 3 Top 30 countries and world regions ranked according to total number of publications (Continued)
Asia 1,397 18.09 Europe 3.50 Europe 0.16 Africa 0.74 Africa 1.12
North Africa 459 5.94 North Africa 1.45 Asia 0.13 Europe 0.34 North Africa 0.72
Africa 169 2.19 Asia 0.43 Oceania 0.12 North Africa 0.25 Europe 0.36
Oceania 99 1.28 Africa 0.31 North America 0.09 Oceania 0.18 Oceania 0.18
Publications per inhabitant, per gross domestic product (GDP), per gross national income (GNI) per capita, and health expenditure (HE) per capita in 7.851
leishmaniasis manuscripts with institutional address of the first author (2001-2010). Docs: documents.
* Number of publications per million of population.
** Number of publications per 1 billion US dollars of gross domestic product (GDP).
*** Number of publications per 100 US dollars of GNI per capita.
**** Number of publications per 10 US dollars of HE per capita.
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http://www.parasitesandvectors.com/content/6/1/55though they do not appear in long-term bibliometric
analyses, they are playing a major role in the area with
a strong research activity.
Although the main language of leishmaniasis research
output is English (82.8%), this language is less common
than other bibliometric studies based on PubMed, where
85-90% of its documents are in English [8,9]. The other
more important languages were French and Portuguese.
Leishmaniasis is endemic in North Africa, France and
Brazil [1], which might explain the prevalence of these
languages with respect to others. For instance, the
geographic distribution of the disease is important with
the publication language about the disease [26]. For this,
reviewing the journals in the original language of
geographical distribution of the diseases is interesting.
Journal articles were the most commonly retrieved
document type (approximately 90%), similar to other biblio-
metric studies on NTDs and non-NTDs [8-10,17,18].
Although controlled trials offer the best evidence for med-
ical intervention efficacy [27], in this study they represented
only 0.3% of the documents, a figure lower than in other
fields [8,9] and similar to other NTDs [18].
Nucleus journals usually contain articles with the highest
impact in the area and thus, subscriptions to such journals
in indexing and abstracting services would be justified
scientifically [10,28]. Most top journals publishing on
leishmaniasis were from the parasitology, immunology, and
tropical medicine subject categories. The top journal was
Transactions of the Royal Society of Tropical Medicine and
Hygiene from the UK, while the American Journal of
Tropical Medicine and Hygiene from the USA was second.
Both included the public, environmental and occupational
health and tropical medicine subject categories. The fourth
and seventh journals were Memórias do Instituto Oswaldo
Cruz and Annals of Tropical Medicine and Parasitology
including the parasitology and tropical medicine subject
categories. The third and fifth journals were Molecular and
Biochemical Parasitology and Experimental Parasitology;
both journals publish basic aspects of parasitology. The
sixth and eighth journals were the Journal of Immunologyand Infection and Immunology, respectively, both related to
immunology.
USA was the leading country in publication output on
leishmaniasis, like that which has also been described in
other biomedical fields [8-10], although the number of
leishmaniasis cases there is less than in South America.
Brazil, a country with a high prevalence of leishmaniasis,
led scientific production on leishmaniasis in Latin America.
This can be attributed to the number of researchers and
development of the country’s scientific system, which has
become the principal scientific reference for South America
[20,29]. India, a country with a high prevalence of
leishmaniasis, mainly in the state of Bihar [1,2,25,30], was
the third country, and it led scientific production on
leishmaniasis in Asia.
Leishmaniasis research in small countries, after adjusting
for population, was led by Israel and Switzerland. Swiss
publications came mainly from the WHO, especially from
the Programmes of Prevention and Control of Leishmania-
sis and Drugs for Neglected Diseases initiative [1,2].
Although institutions of the United Nations are not attrib-
uted to any country, the WHO is physical located in
Geneva, Switzerland. The leading countries after adjusting
for GDP were low- or middle-income countries with a
higher prevalence of leishmaniasis, like Nepal, Tunisia,
Kenya, Ethiopia and Sudan. When adjusting economic
and demographic aspects (GNI per capita), the leading
countries were low- and middle-income countries with a
higher prevalence of leishmaniasis and overpopulated, like
India, Ethiopia, Pakistan and Brazil [24,30,31].
In visceral leishmaniasis, the leading countries were
India and Brazil, both with high prevalence. Spain was
the third country, probably influenced by the association
of visceral leishmaniasis and HIV infection [32]. In
cutaneous leishmaniasis, Brazil, USA and Germany
topped the rankings.
Europe was the world’s leading area in scientific produc-
tion on leishmaniasis. Although the disease load in Europe
constitutes less than 0.2% of global cases of leishmaniasis,
there are people with Leishmania infections living there,
Table 4 Top 30 countries and word regions ranked according to total number of publications by forms of
leishmaniasis disease
Visceral leishmaniasis Cutaneous leishmaniasis Mucocutaneous leishmaniasis Diffuse cutaneous leishmaniasis
Country N. of
docs
% Country N. of
docs
% Country N. of
docs
% Country N. of
docs
%
India 758 18.6 Brazil 667 19.0 Brazil 133 37.6 Brazil 34 33.3
Brazil 583 14.3 USA 571 16.3 USA 33 9.3 Venezuela 13 12.7
Spain 339 8.3 Germany 202 5.8 France 31 8.8 USA 10 9.8
USA 308 7.5 UK 194 5.5 Colombia 23 6.5 Mexico 9 8.8
France 250 6.1 Iran 183 5.2 Venezuela 18 5.1 Germany 5 4.9
Italy 248 6.1 France 152 4.3 Spain 18 5.1 India 4 3.9
UK 228 5.6 Venezuela 92 2.6 UK 17 4.8 Colombia 3 2.9
Germany 91 2.2 India 91 2.6 Bolivia 13 3.7 France 3 2.9
Sudan 91 2.2 Spain 82 2.3 Peru 11 3.1 Italy 2 2.0
Iran 82 2.0 Colombia 78 2.2 Sudan 7 2.0 Argentina 2 2.0
Netherlands 75 1.8 Switzerland 75 2.1 Italy 5 1.4 Egypt 2 2.0
Tunisia 69 1.7 Israel 74 2.1 Argentina 5 1.4 Iran 2 2.0
Turkey 60 1.5 Tunisia 70 2.0 Germany 5 1.4 Sweden 2 2.0
Greece 59 1.4 Japan 66 1.9 Switzerland 4 1.1 Japan 1 1.0
Portugal 58 1.4 Turkey 63 1.8 India 3 0.8 Lebanon 1 1.0
Canada 57 1.4 Egypt 59 1.7 Japan 3 0.8 Nigeria 1 1.0
Belgium 51 1.2 Canada 58 1.7 Netherlands 3 0.8 Senegal 1 1.0
Switzerland 50 1.2 Italy 57 1.6 Egypt 2 0.6 Spain 1 1.0
Kenya 46 1.1 Pakistan 50 1.4 Tunisia 2 0.6 Burkina Faso 1 1.0
Nepal 45 1.1 Mexico 48 1.4 Israel 2 0.6 Switzerland 1 1.0
Ethiopia 43 1.1 Australia 46 1.3 Denmark 2 0.6 Bolivia 1 1.0
Israel 42 1.0 Argentina 43 1.2 Pakistan 2 0.6 Australia 1 1.0
Venezuela 39 1.0 Kenya 38 1.1 Greece 2 0.6 Tunisia 1 1.0
China 34 0.8 Sudan 34 1.0 Nepal 1 0.3 Iraq 1 1.0
Bangladesh 30 0.7 Saudi Arabia 30 0.9 Madagascar 1 0.3 - - -
Denmark 30 0.7 Netherlands 27 0.8 Iran 1 0.3 - - -
Egypt 29 0.7 Jordan 22 0.6 Panama 1 0.3 - - -
Colombia 26 0.6 Denmark 21 0.6 Canada 1 0.3 - - -
Saudi Arabia 19 0.5 Sri Lanka 20 0.6 Saudi Arabia 1 0.3 - - -
Pakistan 17 0.4 Belgium 19 0.5 Sri Lanka 1 0.3 - - -
World regions N. of
docs
% World regions N. of
docs
% World regions N. of
docs
% World regions N. of
docs
%
Europe 1,554 38.1 Latin America and
the Caribbean
987 28.1 Latin America and
the Caribbean
205 57.9 Latin America and
the Caribbean
62 17.5
Asia 1,022 25.0 Europe 902 25.7 Europe 89 25.1 Europe 14 4.0
Latin America and
the Caribbean
674 16.5 North America 629 17.9 North America 34 9.6 North America 10 2.8
North America 365 8.9 Asia 480 13.7 Asia 12 3.4 Asia 7 2.0
North Africa 244 6.0 North Africa 354 10.1 Africa 8 2.3 North Africa 5 1.4
Africa 204 5.0 Africa 113 3.2 North Africa 6 1.7 Africa 3 0.8
Oceania 18 0.4 Oceania 47 1.3 Oceania 0 0.0 Oceania 1 0.3
Total 4.081 100 Total 3,512 100 Total 354 100 Total 102 100
Docs: documents.
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Figure 4 Research output of different world regions in leishmaniasis documents with institutional address of the first author published
from 1986 to 2010 per 5-year period.
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http://www.parasitesandvectors.com/content/6/1/55especially along the Mediterranean Coast [1]. Europe has
a long tradition of agencies and institutions implementing
research and health programmes in tropical medicine and
parasitology [33-35], in addition to networks of scientists
operating in these countries with other countries where
leishmaniasis is endemic. Latin America was the world’s
second-leading area in scientific production on leishman-
iasis. Its relative contribution increased to 26.8% in the last
5-year study period. This is because of a high prevalence
of this disease on this continent, the long lasting interest
in this field in the Latin American countries, especially
Brazil [19,24,29,35-37], and the incorporation of new Latin
American journals in PubMed. North America was the
world’s third area. However, its relative contribution
decreased to 14.4% in the 2006-2010 period. A decreased
contribution from North America also occurred in other
biomedical fields such as tuberculosis [8]. The absolute
and relative contribution from Asia increased in our study
from 105 (8.8%) in 1986-1990 to 899 (20.5%) in the 2006-
2010 period. This increasing Asian contribution has been
seen in other scientific fields because of their improving
research, including many leishmaniasis clinical trials
conducted on the Indian subcontinent, and increasing
incorporation of new Asians journals in PubMed [38].
The relative contribution from North Africa and the
Middle East, Africa and Oceania was similar during all
5-year periods.Europe and North America are at the vanguard of
scientific excellence and development, and should
increase their collaboration with scientific publications in
developing countries, especially from North Africa and
the Middle East and Africa in the field of leishmaniasis.
Europe was the world leader in visceral leishmaniasis,
followed by Asia. However, Latin America and the
Caribbean ranked first in cutaneous, mucocutaneous and
diffuse cutaneous leishmaniasis.
PubMed and the Science Citation Index were found to
be the most suitable databases for searching and retrieving
references for bibliometric studies [8,21]. We used the
PubMed database because it is easily accessible and widely
used, it uses a controlled vocabulary for indexing and
recovering documents [8,9,39], and the index journal in
Medline has a certain criteria for quality [16,40]. However,
the method we used may have several limitations that have
been explained in other publications [18]. For example,
the database mainly includes journals published in English,
and journals in other languages are less likely to be found
on PubMed. However, this database has more non-English
journals than the Web of Science database [41]. Another
limitation is that in PubMed, only the address of the first
author appears in the journal articles, whereas in letters
and editorials, the address field is not recorded, and the
address has only been included since 1986 and systematic-
ally ever since. For instance, estimating the quantity of
Table 5 Twenty most-productive authors ranked according to total number of publications by forms of the disease
Visceral leishmaniasis Cutaneous leishmaniasis Mucocutaneous leishmaniasis Diffuse cutaneous leishmaniasis
Author N. of docs % Author N. of docs % Author N. of docs % Author N. of docs %
Sundar. S 164 3.9 Scott. Phillip 62 1.8 Marsden. Philip D 68 19.2 Costa. J M 11 3.2
Murray. Henry W 91 2.2 Pratlong. Francine 55 1.6 Carvalho. Edgar M 30 8.5 Convit. Jacinto 11 3.2
Gradoni. Luigi 87 2.1 Sacks. David L 49 1.4 Lainson. Ralph 28 7.9 Saldanha. Ana Cr 11 3.2
Thakur. Chandreshwar P 76 1.9 Barral. Aldina M 47 1.3 Llanos Cuentas. E A 28 7.9 Barral. Aldina M 10 2.9
Boelaert. Marleen 73 1.8 Carvalho. Edgar M 47 1.3 Cuba. C C 23 6.5 Carvalho. Edgar M 9 2.6
El Hassan. Ahmed M 73 1.8 Dedet. Jean Pierre 47 1.3 Convit. Jacinto 23 6.5 Becker. I 6 1.7
Gramiccia. Marina 62 1.5 Louis. Jacques A 40 1.1 Shaw. Jeffrey J 21 5.9 Ulrich. Marian 6 1.7
Pratlong. Francine 62 1.5 Röllinghoff. Martin 40 1.1 Dedet. Jean Pi 20 5.6 Barral Netto. Manoel 5 1.4
Alvar. Jorge 60 1.5 Locksley. Richard M 40 1.1 Costa. J M 19 5.4 Bittencourt. Achiléa L 5 1.4
Marty. Pierre 56 1.4 Mayrink. Wilson 38 1.1 Barreto. A C 19 5.4 Tapia. Felix J 5 1.4
Dedet. Jean P 55 1.3 Handman. Emanuela 37 1.1 Netto. Eduardo M 19 5.4 Galvão. C E 4 1.2
Kaye. Paul M 53 1.3 Launois. Pascal 35 1.0 Saravia. Nancy G 18 5.1 Cáceres Dittmar. G 4 1.2
Kager. Piet A 52 1.3 Barral Netto. Manoel 35 1.0 Pirmez. Claude 17 4.8 Pratlong. Francine 4 1.2
Reed. Steven G 50 1.2 El Hassan. Ahmed M 35 1.0 Grimaldi Júnior. Gabriel 16 4.5 Pacheco de Almeida. Roque 3 0.9
Rijal. Suman 50 1.2 Titus. Richard G 34 1.0 Barral. Aldina Maria P 16 4.5 Dedet. Jean P 3 0.9
Badaró. Roberto 47 1.2 Llanos Cuentas. E A 32 0.9 Lessa. Hélio Andrade 16 4.5 Meyer Fernandes. José R 3 0.9
Carvalho. Edgar M 46 1.1 Khamesipour. Ali 30 0.9 Furtado. T A 14 4.0 Machado. Paulo R L 3 0.9
Davidson. Robert N 41 1.0 Shaw. Jeffrey Jon 30 0.9 Sampaio. Raimunda N R 13 3.7 Pérez Montfort. Ruy 3 0.9
Croft. Simon L 41 1.0 Ramesh. Venkatesh 29 0.8 Mayrink. Wilson 13 3.7 Guimarães. Luis H 3 0.9
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not possible. This may cause some problems when esti-
mating research productivity from developing countries
that work in collaboration with scientists from a developed
country. Even though the bibliometric methodology used
may present some limitations and the results could, in
some way, be biased [9,40], we believe that this study rep-
resents a useful tool for scientists and public health policy
makers in planning and organizing research in the field of
leishmaniasis. We should emphasize that other authors
should employ the method we used to find research
production, so that our results may be comparable to
others in the future.
Conclusion
In conclusion, we have found an increase in the number of
publications in the field of leishmaniasis disease. Authors
affiliated to institutions in USA and Brazil led scientific
production on leishmaniasis research. Efforts should be
made to help developing countries with the highest preva-
lence of leishmaniasis develop scientific research networks
(collaborative platforms) with North American and/or
European countries in order to increase research with
interdisciplinary teams [42].
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